Breaking News
December 9, 2018 - Deprescribing could help manage polypharmacy in older adults
December 9, 2018 - FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)
December 9, 2018 - Feds say heroin, fentanyl remain biggest drug threat to US
December 9, 2018 - Eliminating microglia can reverse some aspects of stress sensitization, study shows
December 9, 2018 - New genetic insight could help treat rare debilitating heart and lung condition
December 9, 2018 - MiRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 9, 2018 - Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism
December 9, 2018 - CWRU researcher secures $14.6 million funding for genetic study into Alzheimer’s disease
December 9, 2018 - High intensity statin treatment and adherence could save more lives
December 9, 2018 - Surgery patients use only 1/4 of prescribed opioids, and prescription size matters
December 9, 2018 - AXT offers Phi Optics upgrade to QPI systems for inverted light microscopes
December 9, 2018 - New booklet could help improve conditions of young pupils with albinism
December 9, 2018 - Few Physicians Work in Practices That Use Telemedicine
December 9, 2018 - Older Adults and Oral Health
December 9, 2018 - Health utility values improve after septorhinoplasty
December 9, 2018 - New EU-funded project provides insight into how the brain develops
December 9, 2018 - Expanded use of tele-emergency services can help strengthen rural hospitals
December 9, 2018 - Infections in the Young May Be Tied to Risk for Mental Illness: Study
December 9, 2018 - Profile: Native Hawaiians and Pacific Islanders
December 9, 2018 - Snoring poses greater cardiac risk to women
December 9, 2018 - Researcher takes further steps in understanding how and why cute aggression occurs
December 9, 2018 - Researchers create new light-activated tools for controlling neurons
December 9, 2018 - Spinal cord injury disrupts the body’s internal clock, study shows
December 9, 2018 - Babies recognize nested structures similar to our grammar
December 9, 2018 - UT Austin researcher receives $2.5 million CZI grant for neurodegenerative disease research
December 9, 2018 - Sleep problems found to be prevalent and increasing among college students
December 9, 2018 - Study reveals why some children are susceptible to the effects of maltreatment
December 9, 2018 - Study investigates influence of different opioids on driving performance
December 9, 2018 - Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia
December 9, 2018 - Eliminating microglia prevents heightened immune sensitivity after stress
December 9, 2018 - Boys with social difficulties are at greatest risk of early substance use
December 9, 2018 - ‘Wrong’ connective tissue cells linked to worse prognosis in breast cancer patients
December 8, 2018 - Chronic, refractory schizophrenia patients benefit from targeted cognitive training
December 8, 2018 - Advertising in kids’ apps more prevalent than parents may realize
December 8, 2018 - New way to trace the transmission histories of rare genetic diseases
December 8, 2018 - ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
December 8, 2018 - Results of pediatric genomic epilepsy tests often reclassified
December 8, 2018 - New way of controlling HIV latency to completely eradicate the virus
December 8, 2018 - Phasefocus to showcase the Livecyte 2 at ASCB
December 8, 2018 - KHN’s ‘What the Health?’ Is health spending the next big political issue?
December 8, 2018 - Mussels take in microplastic pollution fibers and flush most of them out again
December 8, 2018 - AHA: How to Stop Smoking … for Good
December 8, 2018 - Scientists overturn odds to make Parkinson’s discovery
December 8, 2018 - Health benefits of producing marula vinegar
December 8, 2018 - Failure of critical cellular energy sensor responsible for CKD progression, study finds
December 8, 2018 - Ethnicity can be reliable indicator of gut microbiota diversity
December 8, 2018 - Safe Sleep for Baby | NIH News in Health
December 8, 2018 - Study looks at ways technology can support nutritional needs of Parkinson’s patients
December 8, 2018 - Infant milk allergy is being overdiagnosed say experts
December 8, 2018 - Graphene may one day be used to test for ALS
December 8, 2018 - Houston Methodist launches real-time website to track flu cases
December 8, 2018 - RedHill Announces Positive Top-Line Results from Confirmatory Phase 3 Study with Talicia for H. pylori Infection
December 8, 2018 - A way to measure obesity and health beyond BMI
December 8, 2018 - New diagnostic tools may help identify breast cancer patients who could benefit from targeted therapies
December 8, 2018 - Duke-NUS researchers highlight possible role of bioaerosol sampling in pandemic surveillance
December 8, 2018 - Study quantifies links between alcohol, drug use and violent deaths
December 8, 2018 - Mothers’ stress levels at conception linked to child’s response to life challenges at age 11
December 8, 2018 - MIT researchers develop antimicrobial peptides from South American wasp’s venom
December 8, 2018 - Obesity prevention among low-income, diverse preschool-aged children and parents
December 8, 2018 - Mount Sinai researcher awarded $2.5 million to advance understanding of neurodegenerative diseases
December 8, 2018 - CZI announces funding for open-source software efforts to improve image analysis in biomedicine
December 8, 2018 - New book encompasses the vast history of reproduction
December 8, 2018 - Low-income women in Texas are not receiving contraception after childbirth, study shows
December 8, 2018 - Study expands knowledge about sexuality and gender gaps in political attitudes
December 8, 2018 - Drug reduces hot flash frequency, improves quality of life in breast cancer survivors
December 8, 2018 - Imaging, Biopsy Often Still Needed After Mastectomy
December 8, 2018 - Physical Activity Guidelines for Americans: 2nd edition
December 8, 2018 - Machine learning can improve chemical toxicity prediction
December 8, 2018 - Researchers explore why and how Mediterranean diet may mitigate cardiovascular risk
December 8, 2018 - Multigene test is a helpful decision making tool in breast cancer treatment, study shows
December 8, 2018 - New EZ-2 centrifugal evaporator to safely remove solvents from cytotoxic drug preparations
December 8, 2018 - UMGCCC uses Gammapod radiotherapy to treat breast cancer patients
December 8, 2018 - Men with inflammatory bowel disease have higher prostate cancer risk
December 8, 2018 - Newly developed molecules may provide more reliable relief for people with autoimmune diseases
December 8, 2018 - Exercise program during adjuvant breast cancer treatment may provide cardiovascular benefits
December 8, 2018 - Acutely injured deceased-donor kidneys are suitable for transplant, study suggests
December 8, 2018 - Researchers find two connective tissue cells to be linked to worse prognosis of breast cancer
December 8, 2018 - VCU researchers test vaccine against opioid abuse
December 8, 2018 - An App, Your Fingernail — and Anemia Screening Is Done
December 8, 2018 - New study offers hope for patients suffering from a rare form of blindness
Nobel-winning therapy weaponises immune system against cancer

Nobel-winning therapy weaponises immune system against cancer

image_pdfDownload PDFimage_print
While chemotherapy destroys cancerous cells along with normal cells, often with toxic and debilitating effects on a patients’ body, immunotherapy unleashes the body’s immune system to target tumour cells

A revolutionary cancer treatment pioneered by the winners of the 2018 Nobel Prize for Medicine has been hailed as the future of fighting the disease—and it has fewer devastating side effects than chemotherapy.

While chemotherapy destroys cancerous cells along with normal cells—often with toxic and debilitating effects on a patient—immunotherapy unleashes the body’s immune system to target tumour cells.

James Allison of the US and Tasuku Honjo of Japan won the Nobel on Monday for identifying two different brakes on the immune system which, when turned off, allow the body’s defence system to attack cancerous cells faster and more effectively.

Allison was one of two scientists to discover the blocking effect for one such brake—or checkpoint inhibitor molecule—called CTLA-4 in 1995. Honjo discovered another, PD-1, around the same time.

Once these brakes were identified, researchers were able to work on how to turn them off and get T-cells—white blood cells—to start attacking.

“The goal is to neutralise these molecules, among them CTLA-4 and PD-1, and these are what the recipients of the Nobel prize have been working on,” said Pierre Golstein, emeritus professor at the Marseille-Luminy Immunology Centre.

“We neutralise these and the white blood cells can get to work on the cancer cells,” he added.

Sheena Cruickshank, an immunology lecturer at the University of Manchester in Britain, said the therapy has “enabled us to harness the power of the body to help heal itself”.

“A lot of conventional cancer therapies are about destroying cells and can be quite damaging, but this is much more targeted and much more specific because it’s enabling our immune cells to come in and actually kill the tumour cells directly,” she told AFP.

Booming field

The therapy has only been used on patients for a few years, and is less effective for certain cancers such as pancreatic and brain cancer.

But 800 clinical trials were in progress worldwide and more than 30 drugs under development as of June, according to the American Cancer Society.

And the pharmaceutical industry has heavily invested in research in the field.

The US Food and Drug Administration has already approved a number of immunotherapy treatments, including some targeting PD-1.

“The booming field of immunotherapy that these discoveries have precipitated is still relatively in its infancy, so it’s exciting to consider how this research will progress in the future,” said Charles Swanton, Cancer Research UK’s chief clinician.

Goldstein, whose team first identified the CTLA-4 molecule in 1987, said the results have been very promising.

“Immunotherapy is now possibly the most important recent discovery for cancer therapy in general, as an alternative to chemo,” he said.

“For example, immunotherapy can control between 20 and 50 percent of certain advanced melanomas, which is something considering that situation would have been a death sentence not too long ago.”

But it’s also not totally harmless, he added.

“Activated immune cells can cause certain auto-immune complications in certain organs, but we can control those,” he said.

A study released in June tested a form of immunotherapy against chemo for non-small-cell lung cancer, the most common lung cancer worldwide.

It found that the drug Keytruda (pembrolizumab)—which famously helped former US president Jimmy Carter stave off advanced melanoma that had spread to his brain—helped lung cancer patients live four to eight months longer than chemo.

Not for all cancers

However, Karl Peggs of the University College of London said the therapy is not for everyone.

“We know that some patients have a very low chance of responding… those with little evidence that these pathways are actively restricting the immune system, or those with cancers that are less heavily mutated,” he said.

While in theory it should work for most forms of cancer, it’s most effective on those with the highest numbers of mutations such as melanomas, lung cancer and smoking, he added.

And it has sometimes been met with too much enthusiasm by patients. In the US, some have reportedly asked their doctors to immediately use immunotherapy instead of traditional treatments like chemotherapy, even when they are more effective.

After his big win on Monday, Allison warned that immunotherapy will not replace all other cancer treatments.

Instead, it is “going to be part of therapy that potentially all cancer patients will receive in five years,” he told a press conference in New York.

Honjo, meanwhile, said he wanted to continue his research “so that this immune therapy will save more cancer patients than ever”.


Explore further:
US, Japan duo win Nobel Medicine Prize for cancer therapy

Tagged with:

About author

Related Articles